The Globe and Mail

Go to the Globe and Mail homepage

Jump to main navigationJump to main content

AdChoices
 

Arena Pharmaceuticals Inc

Nasdaq: ARNA
Last

(U.S.) $1.67

Today's change-0.01 -0.60%
Updated July 29 4:00 PM EDT. Delayed by at least 15 minutes.
 

Arena Pharmaceuticals Inc

Nasdaq: ARNA
Last

(U.S.) $1.67

Today's change-0.01 -0.60%
Updated July 29 4:00 PM EDT. Delayed by at least 15 minutes.

Arena Pharmaceuticals Inc down (U.S.)$0.01

Arena Pharmaceuticals Inc closed lower Friday, dropping (U.S.)$0.01 or 0.60% to (U.S.)$1.67. Over the last five days, shares have lost 0.60% and are down 12.11% for the last year to date. This security has underperformed the S&P 500 by 62.25% during the last year.

Key company metrics

  • Open(U.S.) $1.67
  • Previous close(U.S.) $1.68
  • High(U.S.) $1.70
  • Low(U.S.) $1.66
  • Bid / Ask(U.S.) $1.43 / (U.S.) $1.74
  • YTD % change-12.11%
  • Volume739,472
  • Average volume (10-day)1,615,418
  • Average volume (1-month)1,725,549
  • Average volume (3-month)1,739,896
  • 52-week range(U.S.) $1.30 to (U.S.) $4.17
  • Beta-0.55
  • Trailing P/ENegative, not meaningful
  • P/E 1 year forwardNegative, not meaningful
  • Forward PEGNegative, not meaningful
  • Indicated annual dividend--
  • Dividend yield0.00%
  • Trailing EPS(U.S.) -$0.43
Updated July 29 4:00 PM EDT. Delayed by at least 15 minutes.
  • Income Statement
  • Balance Sheet
  • Cash Flow
Quarter | Annual
Q1/2016Q4/2015Q3/2015Q2/2015
Fiscal Quarter Endvalues in (U.S.) $ millions unless otherwise notedMar 31, 201603/31/2016Dec 31, 201512/31/2015Sep 30, 201509/30/2015Jun 30, 201506/30/2015
Revenue10899
Total other revenue--------
Total revenue10899
Gross profit6566
Total cost of revenue4333
Total operating expense29373436
Selling / general / administrative71099
Research & development19202224
Depreciation / amortization--------
Interest expense (income), net operating--------
Unusual expense (income)--4----
Other operating expenses, total--------
Operating income-19-29-25-27
Interest income (expense), net non-operating-2-2-2-2
Gain (loss) on sale of assets--------
Other--------
Income before tax-22-30-26-27
Income after tax-22-30-26-27
Income tax, total--------
Net income-22-30-26-27
Total adjustments to net income--------
Net income before extra. items-22-30-26-27
Minority interest--------
Equity in affiliates--------
U.S. GAAP adjustment--------
Inc. avail. to common excl. extra. items-22-30-26-27
Inc. avail. to common incl. extra. items-22-30-26-27
Diluted net income-22-30-26-27
Dilution adjustment0--0--
Diluted weighted average shares243243242242
Diluted EPS excluding extraordinary itemsvalue per share-0.09-0.13-0.11-0.11
Dividends per sharevalue per share0.000.000.000.00
Diluted normalized EPSvalue per share-0.09-0.11-0.11-0.11